explore -WSS

explore

author：knowledge 2025-08-26 07:42:34 - browse：93351

Pfizer is this year’s anti-Eli Lilly. If David Ricks is the best biopharma CEO of 2023, then Pfizer CEO Albert Bourlais, unfortunately, the worst.

My annual Worst Biopharma CEO list is typically populated with blockheads and scoundrels. That’s not why Bourla is here. The reason is accountability. Strategic missteps, financial miscalculations, and scientific setbacks have plunged Pfizer into a deep crisis. Bourla is the man at the top, so the responsibility lies with him.

Pfizer shares have fallen 50% this year to their lowest level in more than a decade, erasing nearly $140 billion in market value. In 2022, the company delivered $100 billion in revenue, boosted by a widely used Covid vaccine and Covid treatment. This year, Covid product sales evaporated — and will fall further next year — leaving a vacuum Pfizer is struggling to fill with aging medicines nearing the end of their patent lives, and newer drugs and vaccines that have not performed as expected.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： David Liu startup to focus on CRISPR delivery

focus

hotspot

WSS

US ambassador visits Wall Street Journal reporter detained in Russia on charges of espionage

Why the quest to eradicate polio has stumbled

Trump pressured former Arizona governor to overturn 2020 election results: Sources

4 dead, 2 in stable condition in Philadelphia shooting: Police

Information blocking fines are now fair game in health care

Ukraine holds disaster drills amid fears Russia could sabotage nuclear power plant

Wikipedia

explore

focus

After affirmative action ruling, medical educators look to 'holistic review'

Ukraine holds disaster drills amid fears Russia could sabotage nuclear power plant

Trump demands the U.S. pay no more for drugs than other countries … again

Transgender sports debate: Physicians say bans are health issue

Cancer drug shortages should be causing more outrage

EU climate chief is concerned over the expansion of the coal industry in China

Jerome Adams on the need for new antivirals for Covid

The Democratic Party promised to overhaul its primaries. Doing that has been anything but simple

Affirmative action in medical school literally saved lives

'A game

entertainment

Covid’s new normal has set in amid another rise in cases

Trump pressured former Arizona governor to overturn 2020 election results: Sources

Covid’s new normal has set in amid another rise in cases

PBMs drew scrutiny in House hearing — and so did pharma

Information blocking fines are now fair game in health care

Neurocrine congenital adrenal hyperplasia trial succeeds

focus

leisure time

hotspot

hotspot